... antihypertensive medication. Anaemia was present in 34% of patients and increased markedly with advanced CKD stages. Of patients with documented anaemia, only 19% had received epoetin and only 7% had received iron treatment. Conclusion: IRIDIEM documents the need to improve adherence to current best practice...

..., University of Heidelberg, Mannheim, Germany; F. Hoffmann-La Roche, Global Clinical Drug Development, Basel, Switzerland Key Words Chronic kidney disease Epoetin Target hemoglobin clinical practice. However, until new evidence becomes available from ongoing and future clinical studies, an upper Hb limit...

... advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Biotechnological medicines Epoetin...